Sandler Alan B.
Insider CIK 1835966 · MRTX Chief Medical Officer · RVMD Chief Development Officer · ZLAB Head of Global Dev., Oncology · ELEV Director · ALXO Chief Medical Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines, Inc. | M Exercise deriv | 2026-09-29 | 2026-10-01 | 6,000 | — | $0 | 161,300 | SEC↗ |
| RVMD Revolution Medicines, Inc. | S Sale | 2026-09-29 | 2026-10-01 | 301 | $204.72 | $61.6K | 52,559 | SEC↗ |
| RVMD Revolution Medicines, Inc. | S Sale | 2026-09-29 | 2026-10-01 | 1,199 | $203.91 | $244.5K | 52,860 | SEC↗ |
| RVMD Revolution Medicines, Inc. | S Sale | 2026-09-29 | 2026-10-01 | 1,000 | $202.81 | $202.8K | 54,059 | SEC↗ |
| RVMD Revolution Medicines, Inc. | S Sale | 2026-09-29 | 2026-10-01 | 1,609 | $201.72 | $324.6K | 55,059 | SEC↗ |
| RVMD Revolution Medicines, Inc. | S Sale | 2026-09-29 | 2026-10-01 | 2,200 | $200.82 | $441.8K | 56,668 | SEC↗ |
| RVMD Revolution Medicines, Inc. | M Exercise | 2026-09-29 | 2026-10-01 | 6,000 | $58.84 | $353.0K | 58,868 | SEC↗ |
| RVMD Revolution Medicines, Inc. | S Sale | 2026-09-16 | 2026-09-18 | 5 | $194.96 | $975 | 53,204 | SEC↗ |
| RVMD Revolution Medicines, Inc. | S Sale | 2026-09-16 | 2026-09-18 | 336 | $199.30 | $67.0K | 52,868 | SEC↗ |
| RVMD Revolution Medicines, Inc. | S Sale | 2026-09-16 | 2026-09-18 | 336 | $199.30 | $67.0K | 52,868 | SEC↗ |
| RVMD Revolution Medicines, Inc. | S Sale | 2026-09-16 | 2026-09-18 | 5 | $194.96 | $975 | 53,204 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2026-01-20 | 2026-01-21 | 10,100 | — | $0 | 10,100 | SEC↗ |
| ELEV Elevation Oncology, Inc. | D To issuer deriv | 2025-07-23 | 2025-07-24 | 35,000 | — | $0 | 0 | SEC↗ |
| ELEV Elevation Oncology, Inc. | D To issuer deriv | 2025-07-23 | 2025-07-24 | 55,000 | — | $0 | 0 | SEC↗ |
| ELEV Elevation Oncology, Inc. | D To issuer deriv | 2025-07-23 | 2025-07-24 | 35,000 | — | $0 | 0 | SEC↗ |
| ELEV Elevation Oncology, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 35,000 | — | $0 | 35,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2025-04-11 | 2025-04-15 | 125,000 | — | $0 | 125,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2025-01-21 | 2025-01-23 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2024-11-18 | 2024-11-19 | 600,000 | — | $0 | 600,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2024-08-05 | 2024-08-07 | 40,400 | — | $0 | 40,400 | SEC↗ |
| ELEV Elevation Oncology, Inc. | A Award deriv | 2024-06-13 | 2024-06-17 | 35,000 | — | $0 | 35,000 | SEC↗ |
| ELEV Elevation Oncology, Inc. | A Award deriv | 2024-02-29 | 2024-03-04 | 55,000 | — | $0 | 55,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-23 | 65,000 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-23 | 10,547 | — | $0 | 69,318 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-23 | 17,021 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-23 | 52,297 | — | $0 | 17,021 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2023-12-29 | 2024-01-03 | 17,021 | $58.75 | $1000.0K | 79,318 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2023-08-09 | 2023-08-10 | 22,297 | $37.00 | $825.0K | 62,297 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2022-11-07 | 2022-11-08 | 65,000 | — | $0 | 65,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2022-11-07 | 2022-11-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ZLAB Zai Lab Ltd | A Award deriv | 2022-06-25 | 2022-06-27 | 73,000 | — | $0 | 73,000 | SEC↗ |
| ZLAB Zai Lab Ltd | A Award deriv | 2022-04-01 | 2022-04-05 | 87,699 | — | $0 | 87,699 | SEC↗ |
| ZLAB Zai Lab Ltd | M Exercise deriv | 2022-04-01 | 2022-04-05 | 1,060 | — | $0 | 4,240 | SEC↗ |
| ZLAB Zai Lab Ltd | A Award deriv | 2022-04-01 | 2022-04-05 | 16,692 | — | $0 | 16,692 | SEC↗ |
| ZLAB Zai Lab Ltd | M Exercise | 2022-04-01 | 2022-04-05 | 1,060 | — | $0 | 28,985 | SEC↗ |
| ZLAB Zai Lab Ltd | F Tax w/h | 2021-12-01 | 2021-12-03 | 2,075 | $71.23 | $147.8K | 27,925 | SEC↗ |
| ZLAB Zai Lab Ltd | A Award deriv | 2021-04-01 | 2021-04-05 | 28,000 | — | $0 | 28,000 | SEC↗ |
| ZLAB Zai Lab Ltd | A Award deriv | 2021-04-01 | 2021-04-05 | 5,300 | — | $0 | 5,300 | SEC↗ |